Skip to main content

Table 5 Results of the univariate and multivariate regression analyses for the predictive power of the individual components of the CHA2DS2-VASc-HSF score

From: New CHA2DS2-VASc-HSF score predicts the no-reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction

Variables Unadjusted OR(95% CI) P value Adjusted OR(95% CI) P value
Male sex 0.82(0.46–1.45) 0.491 0.48(0.22–0.99) 0.048
Hypertension 1.67(1.03–2.71) 0.038 1.82(1.04–3.18) 0.035
Age 65–74 years 2.19(1.26–3.82) 0.006 3.33(1.76–6.32) < 0.001
Age ≥ 75 years 2.86(1.43–5.71) 0.003 5.52(2.37–12.87) < 0.001
Diabetes mellitus 1.697(0.995–2.895) 0.052 1.73(0.95–3.17) 0.076
History of heart failure 1.57(0.16–15.2) 0.70 2.06(0.18–23.99) 0.563
History of stroke/TIA 1.76(1.27–2.44) 0.001 2.11(1.45–3.07) < 0.001
Vascular disease 3.27(1.92–5.57) < 0.001 4.37(2.39–7.99) < 0.001
Smoking 1.22(0.74–2.004) 0.435 1.77(0.93–3.38) 0.08
Hyperlipidemia 1.62(0.97–2.71) 0.063 2.71(1.499–4.92) 0.001
Family history 1.83(0.99–3.39) 0.054 2.67(1.299–5.50) 0.008
  1. Abbreviations: TIA transient ischemic attack, OR odds ratio, CI confidence interval